Extended real-world studies of patients continuing semaglutide for 23 years demonstrate stable weight loss with consistent dosing
LEADER, SUSTAIN-6, and REWIND trial outcomes The initial wave of cardiovascular outcome trials (CVOTs) predominantly focused on patients with type 2 diabetes at elevated cardiovascular risk
Alert the anesthesia team right away to recent GLP-1 use and GI symptoms
Some may experience changes more quickly than others, however most people notice a gradual reduction in their appetite during the first week with more changes as time passes and taking weekly injections with consistency. What do I eat when I am not hungry on GLP-1s
El envejecimiento cutneo est influido por factores intrnsecos y extrnsecos y mltiples mecanismos patognicos estn involucrados
For most people, the slower start is worth it because better tolerability leads to better adherence, and adherence is ultimately what produces results